Jackson Web Maestro

Actos  rose to prominence years after the leading diabetes medication, Avandia, was  conclusively linked to increased risks of heart attack, stroke and other forms  of cardiovascular disease.   Despite  numerous FDA warnings and even a US Senate Finance Committee inquiry, the drug  was allowed to remain on the market, ultimately causing more than 83,000 heart  attacks and tens of thousands of deaths.   As Avandia began to be prescribed less, the drug Actos quickly gained  market share, despite the very first tests of the drug showing an increased  risk of Actos bladder cancer.   Now the  FDA has issued a safety warning about bladder cancer and Actos has been  recalled in France,  also because of the bladder cancer risk.    Actos was approved the FDA in 1999 and has been used well over two  million people during some of its peak years.    More research is being done about Actos and bladder cancer in those that  have taken the drug, but in the meantime, just how worried do people taking  Actos need to be about bladder cancer?   Read more at www.actosbladdercancerlawsuits.com.